PTEN (MMAC1) Mutations Are Frequent in Primary Glioblastomas (de novo) but not in Secondary Glioblastomas

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00005072-199807000-00005PMID 9690672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

  1998cited by this paper
• A Molecular Genetic Model of Astrocytoma Histopathology

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Somatic mutations of PTEN in glioblastoma multiforme.

  1997cited by this paper
• DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas

  1997cited by this paper
• PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

  1997cited by this paper
• P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

  1997cited by this paper
• Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas

  1997cited by this paper
• Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

  1996cited by this paper
• Deletion Mapping of Chromosome 10 in Human Glioma

  1996cited by this paper
• Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

  1996cited by this paper
• Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme

  1996cited by this paper
• Molecular cloning, expression, and mapping of the high affinity actin- capping domain of chicken cardiac tensin

  1995cited by this paper
• Reliability of Differential PCR for the Detection of EGFR and MDM2 Gene Amplification in DNA Extracted from FFPE Glioma Tissue

  1995cited by this paper
• Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.

  1995cited by this paper
• Integrin function: molecular hierarchies of cytoskeletal and signaling molecules

  1995cited by this paper
• Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function

  1995cited by this paper
• Two tumor suppressive loci on chromosome 10 involved in human glioblastomas

  1995cited by this paper
• Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

  1994cited by this paper
• Subsets of Glioblastoma Multiforme Defined by Molecular Genetic Analysis

  1993cited by this paper
• Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme

  1993cited by this paper
• p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

  1992cited by this paper
• Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.

  1992cited by this paper

• Genetically encoded biosensor for fluorescence lifetime imaging of PTEN dynamics in the intact brain

  2025cites this paper
• Molecular Biomarkers of Glioma

  2025cites this paper
• Emerging therapies for glioblastoma

  2025cites this paper
• Rodent models of tumours of the central nervous system

  2024cites this paper
• Emerging Therapies for Glioblastoma

  2024cites this paper
• Chromosome 7 gain compensates for chromosome 10 loss in glioma.

  2024cites this paper
• Chromosome 7 to the rescue: overcoming chromosome 10 loss in gliomas

  2024influential citation
• Malignant Glioma.

  2023cites this paper
• Understanding signal transduction pathways to overcome targeted therapy resistance in glioblastoma

  2021cites this paper
• Stromal and Tumor Glioma-Derived Cells with Similar Characteristics have Differences in α-Smooth Muscle Actin Expression and Localization

  2021cites this paper
• Glioblastoma: Molecular profile and immunophenotypic analysis as prognostic tools for tailored therapy and decision making in a recent surgical series

  2020cites this paper
• Zytoplasmatische Sequestrierung von bHLH-Transkriptionsfaktoren in experimentellen Gliomen

  2020cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• Imaging Genomics

  2019cites this paper
• Signal transduction pathways and resistance to targeted therapies in glioma.

  2019cites this paper
• Prognosis and management of gliosarcoma patients: A review of literature.

  2019cites this paper
• Protein Phosphatases—A Touchy Enemy in the Battle Against Glioblastomas: A Review

  2019cites this paper
• Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment

  2019cites this paper
• Rôle de l'intégrine bêta 8 dans le maintien de l'état souche et la radiorésistance des cellules souches de glioblastomes : vers une nouvelle thérapie ciblée

  2018cites this paper
• 15 Regulation of Glioma Stem Cells by the Notch Signaling Pathway : Mechanisms and Therapeutic Implications

  2018cites this paper
• Diffuse Astrocytoma and Oligodendroglioma: An Integrated Diagnosis and Management

  2018cites this paper
• Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma

  2018cites this paper
• Histopathological evaluation of cerebral lesions

  2018cites this paper
• Online Database Featuring Author , Key Word and Full-Text Search WHO Guidelines for Diagnosis of Glial Tumours : What Is Old and What Is New ?

  2018cites this paper
• Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme

  2018cites this paper
• Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences.

  2017cites this paper
• A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth

  2017cites this paper
• High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients

  2017cites this paper
• Recent Advances for Targeted Therapies in Glioblastoma

  2017cites this paper
• Molecular Genetics of Secondary Glioblastoma

  2017cites this paper
• Advances in Biology and Treatment of Glioblastoma

  2017cites this paper
• A novel brain tumour model in zebrafish reveals 1 the role of YAP activation in 2 MAPK/PI3K induced malignant growth

  2016cites this paper
• Estudio de genes y proteínas de autofagia en tumores del sistema nervioso central

  2016cites this paper
• miR-21 Is Linked to Glioma Angiogenesis

  2016cites this paper
• Temozolomide and targeted therapy against epidermal growth factor receptor in glioma

  2016cites this paper
• Structural mutation analysis of PTEN and its genotype‐phenotype correlations in endometriosis and cancer

  2016cites this paper
• Online Database Featuring Author , Key Word and Full-Text Search WHO Guidelines for Diagnosis of Glial Tumours : What Is Old and What Is New ?

  2016cites this paper
• FUNCTION AND MECHANISM OF ALKBH5 IN N6-METHYL-ADENOSINE RNA MODIFICATION IN GLIOBLASTOMA

  2016cites this paper
• Inhibierung der Progression von Glioblastomen durch Blockierung des Insulin-like Growth Factor-1 Rezeptors

  2016cites this paper
• A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas

  2016cites this paper
• Identifikation von Resistenzmechanismen gegenüber EGFR-Tyrosinkinase Inhibitoren in EGFR-amplifizierten und EGFRvIII-positiven Glioblastomen

  2015cites this paper
• Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

  2015cites this paper
• Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAFV600E mutation

  2015cites this paper
• Systems Biology of Glioblastoma Multiforme

  2015cites this paper
• Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

  2015cites this paper
• Adult High-Grade (Diffuse) Glioma

  2015cites this paper
• Notching on Cancer’s Door: Notch Signaling in Brain Tumors

  2015influential citation
• Intratumoral Heterogeneity of Genomic Imbalance in a Case of Epithelioid Glioblastoma with BRAF V600E Mutation

  2014cites this paper
• Die Rolle des EGFR/HER2-Signalwegs in Gehirnmetastasen des Mammakarzinoms

  2014cites this paper
• Characterizing and analyzing disease-related omics data using network modeling approaches

  2014influential citation
• The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme

  2014cites this paper
• Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafish

  2014cites this paper
• Nanoparticle based strategies for the treatment of Glioblastoma

  2014cites this paper
• Signaling Cascades Driving the Malignant Phenotype of Glioma Cells

  2014cites this paper
• Gliosarcoma after diagnosis of fibrillary astrocytoma

  2013cites this paper
• miR-331-3p regulates expression of neuropilin-2 in glioblastoma

  2013cites this paper
• Formylpeptide receptor 1 expression in human glioblastoma

  2013cites this paper
• Novel approaches to glioma drug design and drug screening

  2013cites this paper
• Evolution of radiotherapy and chemotherapy practice in malignant gliomas

  2013cites this paper
• Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.

  2013cites this paper
• Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding

  2013cites this paper
• Sudden, unexpected death due to glioblastoma: report of three fatal cases and review of the literature

  2013cites this paper
• Human Papillomavirus-Associated Subsequent Malignancies among Long-Term Survivors of Pediatric and Young Adult Cancers

  2013cites this paper
• Assessment of genetic markers and glioblastoma stem-like cells in activation of dendritic cells

  2013cites this paper
• Células madre: implicaciones en el desarrollo de tumores cerebrales

  2012cites this paper
• Neuronatin in a Subset of Glioblastoma Multiforme Tumor Progenitor Cells Is Associated with Increased Cell Proliferation and Shorter Patient Survival

  2012cites this paper
• Clinicopathologic and genomic features of gliosarcomas

  2012cites this paper
• The Definition of Primary and Secondary Glioblastoma

  2012cites this paper
• Nouvelles approches thérapeutiques pour le traitement du glioblastome : exemple du développement d'une protéine pro-apoptotique

  2012cites this paper
• Genomic Analysis of Pathway Signaling in Glioblastoma and Other Cancers

  2012influential citation
• [Stem cells: implications in the development of brain tumors].

  2012cites this paper
• Frequent BRAF Gain in Low‐Grade Diffuse Gliomas with 1p/19q Loss

  2012cites this paper
• DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome

  2012cites this paper
• Structure and Kinetics of the PTEN Tumor Suppressor: Investigation of Solution and Membrane-Associated States

  2012cites this paper
• Analysis of Chromosome 19q13.42 Amplification in Embryonal Brain Tumors with Ependymoblastic Multilayered Rosettes

  2012cites this paper
• The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.

  2012cites this paper
• Silenciamento de XIAP potencializa os efeitos da superexpressão de TP53 na redução da proliferação e aumento da morte celular em gliomas

  2012cites this paper
• Downstream effects of master regulators in two brain diseases.

  2012cites this paper
• 9 – Histopathology of brain tumors

  2012cites this paper
• Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas

  2012cites this paper
• Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patients

  2011cites this paper
• Aberrant Signaling Pathways in Glioma

  2011cites this paper
• The phosphoinositide 3-kinase signaling pathway as a therapeutic target in grade IV brain tumors.

  2011cites this paper
• Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.

  2011cites this paper
• Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population‐based study

  2011cites this paper
• Regulation of Glioma Stem Cells by the Notch Signaling Pathway: Mechanisms and Therapeutic Implications

  2011influential citation
• Gliosarcoma arising from a fibrillary astrocytoma.

  2011cites this paper
• The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: a clinicopathologic and immunohistochemical study of seven cases at a single institution.

  2011cites this paper
• Molecular Abnormalities in Gliomas

  2011cites this paper
• Alterations in the RB1 Pathway in Low‐grade Diffuse Gliomas Lacking Common Genetic Alterations

  2011cites this paper
• Glioblastomas With Giant Cell and Sarcomatous Features in Patients With Turcot Syndrome Type 1: A Clinicopathological Study of 3 Cases

  2010cites this paper
• Cancer treatment strategies targeting sphingolipid metabolism.

  2010cites this paper
• Estudo de marcadores de diagnóstico e prognóstico em gliomas

  2010cites this paper
• Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients

  2010cites this paper
• Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.

  2010cites this paper
• The PEA-15 Protein Regulates Autophagy via Activation of JNK*

  2010cites this paper
• [Glioblastoma: clinical, radiological and biological prognostic factors].

  2010cites this paper
• Glioblastomes lioblastomes : facteurs pronostiques cliniques , radiologiques et biologiques lioblastoma : Clinical , radiological and biological prognostic factors

  2010cites this paper
• Review Genetic Pathways to Primary and Secondary Glioblastoma

  2010cites this paper
• Status of PI3K inhibition and biomarker development in cancer therapeutics.

  2010cites this paper